Tevogen Bio (TVGN) News Today $1.38 -0.04 (-2.82%) (As of 09:40 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Tevogen reports Q3 EPS (3c) vs (3c) last yearNovember 20 at 9:23 AM | markets.businessinsider.comTevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business ModelNovember 19 at 4:50 PM | globenewswire.comUPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly FinancialsNovember 14, 2024 | globenewswire.comTevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly FinancialsNovember 14, 2024 | globenewswire.comTevogen Bio Shares Are On The Rise Monday: What's Going On?November 11, 2024 | benzinga.comTevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued OperationsNovember 8, 2024 | globenewswire.comTevogen Bio advances HPV oncology treatment TVGN 920November 7, 2024 | uk.investing.comTevogen Bio partners Microsoft for HPV treatmentNovember 6, 2024 | finance.yahoo.comTevogen Bio boekt vooruitgang met HPV-oncologiebehandeling TVGN 920November 6, 2024 | nl.investing.comTevogen leverages Microsoft partnership to deliver target identification for HPVNovember 5, 2024 | markets.businessinsider.comTevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920November 5, 2024 | globenewswire.comTevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient SupportNovember 4, 2024 | globenewswire.comTevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing CostsOctober 31, 2024 | globenewswire.comTevogen Bio Inc: Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the CompanyOctober 30, 2024 | finanznachrichten.deTevogen regains compliance with NasdaqOctober 30, 2024 | markets.businessinsider.comTevogen Bio plant nieuwe R&D- en productiefaciliteitOctober 29, 2024 | nl.investing.comTevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the CompanyOctober 29, 2024 | globenewswire.comAlpha Capital Appointed as Exclusive Financial Advisor to CD8 Technology to Secure Funding Up To $50 MillionOctober 29, 2024 | globenewswire.comTevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder EquityOctober 29, 2024 | globenewswire.comTevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic AreasOctober 25, 2024 | globenewswire.comTevogen Bio (NASDAQ:TVGN) Shares Gap Down - Time to Sell?Tevogen Bio (NASDAQ:TVGN) Shares Gap Down - What's Next?October 25, 2024 | marketbeat.comShort Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Expands By 450.9%Tevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 3,190,000 shares, an increase of 450.9% from the September 30th total of 579,000 shares. Currently, 14.5% of the shares of the company are short sold. Based on an average daily volume of 13,960,000 shares, the short-interest ratio is currently 0.2 days.October 25, 2024 | marketbeat.comTevogen AI joins Microsoft for StartupsOctober 23, 2024 | markets.businessinsider.comTevogen Bio Shares Are Soaring Wednesday: What's Going On?October 23, 2024 | msn.comTevogen Bio's Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug DevelopmentOctober 23, 2024 | globenewswire.comTevogen says CSO share sale ‘solely’ to satisfy payment of tax obligationsOctober 22, 2024 | markets.businessinsider.comTevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This WeekOctober 22, 2024 | globenewswire.comInsider Selling: Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Insider Sells 1,078,600 Shares of StockOctober 22, 2024 | insidertrades.comTevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 BillionOctober 21, 2024 | globenewswire.comTevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming DaysOctober 21, 2024 | globenewswire.comTevogen Bio projects $1 billion oncology revenueOctober 20, 2024 | investing.comTevogen CEO Expresses Gratitude for Unprecedented Public Support of Company's Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming DaysOctober 18, 2024 | globenewswire.comTevogen Bio Holdings Inc. (TVGN)October 17, 2024 | finance.yahoo.comTevogen Bio voorspelt $1 miljard omzet in oncologieOctober 17, 2024 | nl.investing.comTevogen Bio Shares Pop After Positive Guidance for Pipeline Cancer TreatmentsOctober 17, 2024 | marketwatch.comWhy Is Small-Cap Tevogen Bio Stock Rocketing Higher On Thursday?October 17, 2024 | benzinga.comTevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to FollowOctober 17, 2024 | globenewswire.comTevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 BillionOctober 17, 2024 | globenewswire.comTevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical LesionsOctober 15, 2024 | globenewswire.comTevogen Bio Highlights the Publication of Promising Trial Data as the CEO Expresses Optimism About the Company's Scientific Breakthrough in Mainstreaming Cell Therapy Through a New Class of Off-the-Shelf T-Cell Therapies, Manufactured and Stored for Immediate UseOctober 15, 2024 | globenewswire.comTevogen CEO Reaffirms the Company's Commitment to Closing the Information Gap on Its Multi-Billion-Dollar Assets, Following the Release of Revenue ProjectionsOctober 14, 2024 | globenewswire.comTevogen Bio Inc: Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVIDOctober 11, 2024 | finanznachrichten.deTevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024October 11, 2024 | globenewswire.comTevogen Bio Extends Pipeline Prioritizing Oncology and Long COVIDOctober 11, 2024 | globenewswire.comTevogen meldt veilige resultaten van COVID-19-therapieproefOctober 9, 2024 | nl.investing.comTevogen Bio Highlights Promising Trial Data as CEO Leads Patient Advocacy at Capitol Hill, Pledging to Leverage Multi-Billion Dollar Company Assets to Combat Long COVID and Spearhead a New Wave of Medical InnovationOctober 8, 2024 | globenewswire.comTevogen Bio Holdings (NASDAQ:TVGN) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comTevogen Bio Holdings (NASDAQ:TVGN) Stock, Short Interest ReportOctober 3, 2024 | benzinga.comTevogen Bio Leadership Meets Members of U.S. Congress to Advocate for Long COVID Patients and Highlights Achievements and Assets as a Blueprint for Biotech InnovationSeptember 24, 2024 | globenewswire.comTevogen Bio (NASDAQ:TVGN) Shares Up 4.5%Tevogen Bio (NASDAQ:TVGN) Stock Price Up 4.5%September 21, 2024 | marketbeat.com Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide TVGN Media Mentions By Week TVGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TVGN News Sentiment▼-0.130.46▲Average Medical News Sentiment TVGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TVGN Articles This Week▼43▲TVGN Articles Average Week Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LENZ Therapeutics News Today Immatics News Today Vir Biotechnology News Today Relay Therapeutics News Today Replimune Group News Today Autolus Therapeutics News Today CARGO Therapeutics News Today Cullinan Therapeutics News Today Anavex Life Sciences News Today Tectonic Therapeutic News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TVGN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
